NCT04307615

Brief Summary

In swimming induced pulmonary edema (SIPE), there is a lack of knowledge regarding optimal treatment. The present study was designed to assess the benefit of continuous positive airway pressure (CPAP) compared to oxygen as a first line treatment of SIPE in the out-of-hospital environment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
14mo left

Started Jul 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Jul 2022Jul 2027

First Submitted

Initial submission to the registry

February 4, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 13, 2020

Completed
2.3 years until next milestone

Study Start

First participant enrolled

July 2, 2022

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2027

Last Updated

February 27, 2025

Status Verified

February 1, 2025

Enrollment Period

5 years

First QC Date

February 4, 2020

Last Update Submit

February 25, 2025

Conditions

Keywords

continuous positive airway pressure (CPAP)oxygentherapeuticsultrasonographyoximetry

Outcome Measures

Primary Outcomes (1)

  • Absolute peripheral oxygen saturation (%) after treatment

    Peripheral oxygen saturation % (continuous variable) measured by peripheral pulse oximetry

    after 20 min treatment followed by 10 min rest

Secondary Outcomes (9)

  • Change in absolute peripheral oxygen saturation (%) before and after treatment

    change before versus after 20 min treatment followed by 10 min rest

  • Recovery (yes/no) after treatment

    after 20 min treatment followed by 10 min rest

  • Interstitial syndrome assessed by lung ultrasound (yes/no) after treatment

    after 20 min treatment followed by 10 min rest

  • Absolute number of regions presenting B-lines on lung ultrasound after treatment

    after 20 min treatment followed by 10 min rest

  • Change in absolute number of regions presenting B-lines on lung ultrasound before and after treatment

    change before versus after 20 min treatment followed by 10 min rest

  • +4 more secondary outcomes

Study Arms (2)

Oxygen + CPAP-treatment

EXPERIMENTAL
Combination Product: Oxygen + continuous positive airway pressure (CPAP)

Oxygen-treatment

ACTIVE COMPARATOR
Drug: Oxygen

Interventions

Oxygen-driven CPAP (7,5 cmH2O): 20 min treatment followed by 10 min rest and assessment

Oxygen + CPAP-treatment
OxygenDRUG

Oxygen: 20 min treatment followed by 10 min rest and assessment

Oxygen-treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • clinical diagnosis of swimming induced pulmonary edema (SIPE) with need of acute treatment (oxygen saturation ≤91%)
  • years and older
  • informed consent

You may not qualify if:

  • declined consent
  • suspected acute coronary syndrome
  • severe asthma diagnosed together with pulmonary edema where beta-agonist-inhalation is needed prior to treatment of pulmonary edema
  • hemodynamic instability or decreased consciousness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center of Clinical Research Dalarna

Falun, 79182, Sweden

RECRUITING

MeSH Terms

Conditions

Pulmonary EdemaLung Diseases

Interventions

OxygenContinuous Positive Airway Pressure

Condition Hierarchy (Ancestors)

Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

ChalcogensElementsInorganic ChemicalsGasesPositive-Pressure RespirationRespiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Central Study Contacts

Maria Hårdstedt, MD/PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Maria Hårdstedt, PhD, Specialist Internal Medicine

Study Record Dates

First Submitted

February 4, 2020

First Posted

March 13, 2020

Study Start

July 2, 2022

Primary Completion (Estimated)

July 15, 2027

Study Completion (Estimated)

July 15, 2027

Last Updated

February 27, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations